SP
Supernus Pharmaceuticals Inc
🇩🇪XFRA.S49GermanyHealthcare
€35.80EURunchanged 0.00 (0%)OpenEnd of day7:51 PM
Price€35.800.00 (0%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US8684591089
- CUSIP
- Not reported
Company
- Employees
- 778
- Headquarters
- Rockville, United States
- Website
- https://www.supernus.com
- CEO
- Mr. Jack A. Khattar M.B.A.
Market
- Shares outstanding
- 57.3M
- Market cap
- €2.05B
Highlights
No high and low reported for today's session.
- Market cap
- €2.05B
- EPS LTM
- -$1.92calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $830.44M+24.85%up year on year
- Net income
- -$109.89M-270.37%down year on year
- Gross margin
- 88.07%-0.52%down year on year
- Free cash flow
- $18.79M-89.89%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.